ELFORD HOWARD L has a total of 17 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and machines are ABERG A K GUNNAR, CLS PHARMACEUTICALS INC and SNORRASON ERNIR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Machines | |
#4 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Elford Howard L | 17 |
#2 | Van T Riet Bartholomeus | 7 |
#3 | Wampler Galen L | 2 |
#4 | Cardounel Arturo J | 2 |
Publication | Filing date | Title |
---|---|---|
US2009047250A1 | Methods for treating or preventing neuroinflammation or autoimmune diseases | |
CA2638175A1 | Methods for treating or preventing neuroinflammation or autoimmune disease | |
US2008050414A1 | Methods for treating or preventing restenosis and other vascular proliferative disorders | |
CA2298523A1 | Therapeutic process for inhibiting nf-.kappa.b | |
US5366996A | Method of treating hemoglobinopathies | |
EP0610444A1 | Use of a polyhydroxybenzamide or a derivative thereof in the manufacture of a medicament for treating viral infectious diseases | |
US5350770A | Therapeutic process for the treatment of septic shock | |
EP0140958A1 | Oncolytic drug combinations. |